Mark Sievert

1.0k total citations
4 papers, 216 citations indexed

About

Mark Sievert is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Mark Sievert has authored 4 papers receiving a total of 216 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 2 papers in Oncology and 1 paper in Genetics. Recurrent topics in Mark Sievert's work include Cell death mechanisms and regulation (2 papers), RNA Interference and Gene Delivery (1 paper) and Cancer-related Molecular Pathways (1 paper). Mark Sievert is often cited by papers focused on Cell death mechanisms and regulation (2 papers), RNA Interference and Gene Delivery (1 paper) and Cancer-related Molecular Pathways (1 paper). Mark Sievert collaborates with scholars based in Germany, United States and France. Mark Sievert's co-authors include Michael Clemens, Rolf Mahlberg, Volker Rethwisch, S. Al-Batran, Stephan Probst, Jan Stoehlmacher, J. T. Hartmann, G. Seipelt, Nils Homann and Mary Ann Fritz and has published in prestigious journals such as Annals of Oncology and Cancer Medicine.

In The Last Decade

Mark Sievert

4 papers receiving 211 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Sievert Germany 4 165 94 88 69 29 4 216
Nanfeng Fan China 9 152 0.9× 74 0.8× 112 1.3× 53 0.8× 52 1.8× 22 238
J.F. Paitel France 5 226 1.4× 106 1.1× 166 1.9× 62 0.9× 27 0.9× 7 279
Meng‐Shun Sun Taiwan 8 137 0.8× 187 2.0× 90 1.0× 73 1.1× 85 2.9× 15 307
Yusuke Shimodaira United States 7 144 0.9× 118 1.3× 51 0.6× 53 0.8× 37 1.3× 18 219
Sung Jo Bang South Korea 6 195 1.2× 196 2.1× 86 1.0× 38 0.6× 18 0.6× 21 265
Alessia D’Ignazio Italy 9 155 0.9× 113 1.2× 42 0.5× 96 1.4× 20 0.7× 22 242
Marie Washio Japan 10 181 1.1× 139 1.5× 56 0.6× 56 0.8× 70 2.4× 37 278
Yuriy Ostapenko Ukraine 3 149 0.9× 73 0.8× 131 1.5× 62 0.9× 23 0.8× 6 227
Philipp Schüler Germany 7 68 0.4× 85 0.9× 59 0.7× 75 1.1× 17 0.6× 9 159

Countries citing papers authored by Mark Sievert

Since Specialization
Citations

This map shows the geographic impact of Mark Sievert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Sievert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Sievert more than expected).

Fields of papers citing papers by Mark Sievert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Sievert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Sievert. The network helps show where Mark Sievert may publish in the future.

Co-authorship network of co-authors of Mark Sievert

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Sievert. A scholar is included among the top collaborators of Mark Sievert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Sievert. Mark Sievert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

4 of 4 papers shown
1.
2.
Rom, Joachim, Gϋnter von Minckwitz, Frederik Marmé, et al.. (2009). Phase I study of apoptosis gene modulation with oblimersen within preoperative chemotherapy in patients with primary breast cancer. Annals of Oncology. 20(11). 1829–1835. 14 indexed citations
3.
Rom, Joachim, Gϋnter von Minckwitz, W. Eiermann, et al.. (2008). Oblimersen combined with docetaxel, adriamycin and cyclophosphamide as neo-adjuvant systemic treatment in primary breast cancer: final results of a multicentric phase I study. Annals of Oncology. 19(10). 1698–1705. 13 indexed citations
4.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nanfeng Fan Breakdown of academic impact, for papers by J.F. Paitel Breakdown of academic impact, for papers by Meng‐Shun Sun Breakdown of academic impact, for papers by Yusuke Shimodaira Breakdown of academic impact, for papers by Sung Jo Bang Breakdown of academic impact, for papers by Alessia D’Ignazio Breakdown of academic impact, for papers by Marie Washio Breakdown of academic impact, for papers by Yuriy Ostapenko Breakdown of academic impact, for papers by Philipp Schüler
Rankless by CCL
2026